Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Natera, Inc. (NTRA : NSDQ)

• Company Description    Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. Number of Employees: 4,434

• Price / Volume Information    Yesterday's Closing Price: $143.38 Daily Weekly Monthly 20 Day Moving Average: 1,213,664 shares Shares Outstanding: 136.55 (millions) Market Capitalization: $19,578.05 (millions) Beta: 1.73 52 Week High: $183.00 52 Week Low: $92.14 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -16.14% -20.36% 12 Week -7.19% -19.16% Year To Date -9.43% -15.40%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 13011 McCallen Pass Building A Suite 100 - Austin,TX 78753 USA ph: 650-980-9190 fax: - investor@natera.com http://www.natera.com

• General Corporate Information    Officers Steve Chapman - Chief Executive Officer and President Matthew Rabinowitz - Executive Chairman Michael Brophy - Chief Financial Officer Roy Baynes - Director Roelof F. Botha - Director Peer Information Natera, Inc. (CHCR) Natera, Inc. (ESRX) Natera, Inc. (MYDP) Natera, Inc. (COR) Natera, Inc. (GBCS) Natera, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 632307104 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/14/25 Share - Related Items Shares Outstanding: 136.55 Most Recent Split Date: (:1) Beta: 1.73 Market Capitalization: $19,578.05 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.51 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.10 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 7.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/14/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 15.64 Price/Cash Flow: - Price / Sales: 10.69 EPS Growth vs. Year Ago Period: 10.71% vs. Previous Quarter: -21.95% Sales Growth vs. Year Ago Period: 36.46% vs. Previous Quarter: 5.41% ROE 06/30/25 - - 03/31/25 - -18.29 12/31/24 - -20.56 ROA 06/30/25 - - 03/31/25 - -11.68 12/31/24 - -12.21 Current Ratio 06/30/25 - - 03/31/25 - 3.87 12/31/24 - 4.00 Quick Ratio 06/30/25 - - 03/31/25 - 3.74 12/31/24 - 3.87 Operating Margin 06/30/25 - - 03/31/25 - -10.36 12/31/24 - -11.22 Net Margin 06/30/25 - - 03/31/25 - -10.36 12/31/24 - -11.22 Pre-Tax Margin 06/30/25 - - 03/31/25 - -10.34 12/31/24 - -11.18 Book Value 06/30/25 - - 03/31/25 - 9.17 12/31/24 - 9.05 Inventory Turnover 06/30/25 - - 03/31/25 - 15.14 12/31/24 - 15.19 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©